13 Patents
- US125954692026Treatment of Retinitis Pigmentosa Using Improved Engineered Meganucleases
Precision Biosciences, Inc.
0 cites - US125954702026Engineered Nucleases That Target Human and Canine Factor VIII Genes as a Treatment for Hemophilia A
Precision Biosciences, Inc.
0 cites - US124486132025Genetically-modified T Cells Comprising a Modified Intron in the T Cell Receptor Alpha Gene
Precision Biosciences, Inc.
0 cites - US124104182025Optimized Engineered Meganucleases Having Specificity for a Recognition Sequence in the Hepatitis B Virus Genome
Precision Biosciences, Inc.
0 cites - US123518392025Rationally-designed Single-chain Meganucleases with Non-palindromic Recognition Sequences
Precision Biosciences, Inc.
0 cites - 0 cites
- US120065222024Polynucleotides Encoding Engineered Meganucleases Having Specificity for Recognition Sequences in the Dystrophin Gene
Precision Biosciences, Inc.
0 cites - US119937932024Polynucleotides Encoding Engineered Meganucleases Having Specificity for Recognition Sequences in the Dystrophin Gene
Precision Biosciences, Inc.
0 cites - US118667472024Engineered Meganucleases That Target Human Mitochondrial Genomes
Precision Biosciences, Inc.
0 cites - US117865542023Optimized Engineered Nucleases Having Specificity for the Human T Cell Receptor Alpha Constant Region Gene
Precision Biosciences, Inc.
0 cites - US117880772023Polynucleotides Encoding Optimized Engineered Meganucleases Having Specificity for a Recognition Sequence in the Hepatitis B Virus Genome
Precision Biosciences, Inc.
0 cites - US117536302023Polynucleotides Encoding Engineered Meganucleases Having Specificity for Recognition Sequences in the Dystrophin Gene
Precision Biosciences, Inc.
0 cites - US116802542023Engineered Meganucleases Specific for Recognition Sequences in the PCSK9 Gene
PRECISION BIOSCIENCES, Inc.
0 cites